XML 56 R35.htm IDEA: XBRL DOCUMENT
v3.22.4

Issuances of Common Stock (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
ATM Program |
Class of Stock [Line Items] |
Schedule of common stock issuances | The following table outlines common stock issuances pursuant to our ATM programs (dollars in millions):
|  |  | Years ended December 31,
|  |  |  |  | 2022 |  | 2021 |  | 2020
Shares of common stock issued under the ATM program(1) |  |  |  |  | 68,608,176 |  | 46,290,540 |  | 17,724,374
Gross proceeds |  |  |  |  | $ | 4,599.4 |  |  | $ | 3,207.9 |  |  | $ | 1,094.9 |
Sales agents' commissions |  |  |  |  | (34.3) |  |  | (27.3) |  |  | (14.6) |
Other offering expenses |  |  |  |  | (9.1) |  |  | (1.1) |  |  | (0.4) |
Net proceeds |  |  |  |  | $ | 4,556.0 |  |  | $ | 3,179.5 |  |  | $ | 1,079.9 |
(1) During the year ended December 31, 2022, 65,279,851 shares were sold and 58,534,967 settled pursuant to forward sale confirmations. In addition, as of December 31, 2022, 6,744,884 shares of common stock subject to forward sale confirmations have been executed at a weighted average initial price of $63.31 per share but not settled. Upon settlement, subject to certain exceptions, we may elect, in our sole discretion, to cash settle or net share settle all or any portion of our obligations under any forward sale agreement, in which cases we may not receive any proceeds (in the case of cash settlement) or will not receive any proceeds (in the case of net share settlement), and we may owe cash (in the case of cash settlement) or shares of our common stock (in the case of net share settlement) to the relevant forward purchaser. We currently expect to fully physically settle any forward sale agreement with the respective forward purchaser on one or more dates specified by us on or prior to the maturity date of such forward sale agreement, in which case we expect to receive aggregate net cash proceeds at settlement equal to the number of shares specified in such forward sale agreement multiplied by the relevant forward price per share. We currently expect to fully settle the outstanding forward sale agreements during the three months ended March 31, 2023, representing $0.4 billion in net proceeds, for which the weighted average forward price at December 31, 2022 was $62.59 per share. Our forward sale confirmations are accounted for as equity instruments, as we have determined the agreements meet the derivatives and hedging guidance scope exception. No shares were sold pursuant to forward sale confirmations during years ended December 31, 2021 and 2020.
DRSPP |
Class of Stock [Line Items] |
Schedule of common stock issuances | The following table outlines common stock issuances pursuant to our DRSPP program (dollars in millions):
|  |  | Years ended December 31, |
|  |  |  |  | 2022 |  | 2021 |  | 2020
Shares of common stock issued under the DRSPP program |  |  |  |  | 175,554 |  | 168,000 |  | 149,289 |
Gross proceeds |  |  |  |  | $ | 11.7 |  |  | $ | 11.2 |  |  | $ | 9.1 |  |

X
- Definition Schedule Of Common Stock Issuances + References No definition available. + Details
Name: | o_ScheduleOfCommonStockIssuancesTableTextBlock
Namespace Prefix: | o_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ClassOfStockLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=o_AtTheMarketProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=o_DividendReinvestmentAndStockPurchasePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |